Exyte Finalizes the Integration of Pharmaplan
Exyte has successfully integrated Pharmaplan, marking a significant milestone in the evolution of biopharma engineering within Europe. This integration unifies Exyte’s capabilities, creating a powerful force in biopharma engineering.
Strengthening Client Demand and Operational Efficiency
The completion of this integration is expected to accelerate client demand significantly. Exyte is on track for a record order intake in 2025. With a strong foundation laid by Pharmaplan's established expertise, the merged entity is well-positioned to tackle the increasing needs of the life sciences market.
A Unified Approach to Project Delivery
Across key life sciences markets, Exyte will provide end-to-end EPC and EPCM delivery. This includes services spanning from feasibility studies to qualified handovers, ensuring comprehensive support at every project phase. The convergence of expertise allows clients to benefit from seamless solutions in project execution.
Cutting-edge Life Sciences Services Across Europe
Exyte's innovative services now extend to over 40 locations across 12 countries in Europe. This broad presence ensures that the company remains close to key clients in critical pharma and biotech markets. Exyte's ability to provide holistic EPC solutions signifies its commitment to the life sciences sector.
Enhancing Competitive Edge in the Market
As the life sciences landscape continues to grow and evolve, trends such as mRNA technology and gene therapies are reshaping the industry. Exyte’s integrated approach focuses on speed to market while adhering to strict regulatory compliance, making it a crucial partner for clients looking to innovate rapidly in this competitive environment.
Leveraging Global Expertise in Life Sciences
Exyte boasts a global network of subject matter experts, providing unparalleled insights into cleanroom and contamination control processes. With a commitment to high-quality project delivery, these specialists employ cutting-edge digital engineering techniques, including model-based design and AI-assisted methodologies. This expertise enables complex projects to proceed with efficiency and consistency.
A Legacy of Excellence
With over fifty years of experience in GMP-regulated environments, Exyte has established itself as a pioneer in cleanroom engineering. Its longstanding partnerships with major biopharmaceutical companies are a testament to its commitment to innovation and excellence.
About Exyte
Exyte stands as a global leader in the design, engineering, and delivery of ultra-clean and sustainable facilities in high-tech industries. Its expertise, refined over more than a century, aids clients in sectors like semiconductors, biotechnology, and pharmaceuticals. Providing end-to-end services ranging from consulting to implementation, Exyte ensures the highest standards of safety and quality for clients everywhere. In shaping the future, Exyte enables key industries to enhance the quality of modern life.
Frequently Asked Questions
What is the significance of Exyte's integration of Pharmaplan?
The integration signifies a unified approach in biopharma engineering, enhancing Exyte's capabilities and market position.
How does this integration impact client demand?
The alignment of services is expected to drive strong client demand, contributing to a record order intake for Exyte in 2025.
What services does Exyte provide in the life sciences sector?
Exyte offers end-to-end EPC and EPCM services, covering all stages from feasibility studies to handovers, ensuring comprehensive project execution.
How does Exyte ensure regulatory compliance?
Exyte utilizes standardized methodologies and digital engineering to ensure projects adhere to strict regulatory frameworks, maintaining compliance.
What is Exyte’s history and expertise?
With over fifty years in GMP-regulated environments, Exyte has built a legacy of delivering high-quality cleanroom and contamination control projects.
